CA2076625A1 - Aqueous phospholipid vesicle dispersion, process for its manufacture and use thereof - Google Patents
Aqueous phospholipid vesicle dispersion, process for its manufacture and use thereofInfo
- Publication number
- CA2076625A1 CA2076625A1 CA002076625A CA2076625A CA2076625A1 CA 2076625 A1 CA2076625 A1 CA 2076625A1 CA 002076625 A CA002076625 A CA 002076625A CA 2076625 A CA2076625 A CA 2076625A CA 2076625 A1 CA2076625 A1 CA 2076625A1
- Authority
- CA
- Canada
- Prior art keywords
- weight
- phosphatidylcholine
- oil
- substance
- vesicle dispersion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000006185 dispersion Substances 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title claims abstract description 7
- 150000003904 phospholipids Chemical class 0.000 title claims abstract description 7
- 238000004519 manufacturing process Methods 0.000 title claims 2
- 239000000126 substance Substances 0.000 claims abstract description 17
- 239000000203 mixture Substances 0.000 claims abstract description 11
- 239000012528 membrane Substances 0.000 claims abstract description 9
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims abstract description 8
- 239000002537 cosmetic Substances 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 claims description 3
- 238000000265 homogenisation Methods 0.000 claims description 3
- 150000007530 organic bases Chemical class 0.000 claims description 3
- 150000003905 phosphatidylinositols Chemical class 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 2
- 208000002352 blister Diseases 0.000 claims description 2
- 239000005486 organic electrolyte Substances 0.000 claims 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims 2
- 150000007529 inorganic bases Chemical class 0.000 claims 2
- 229940067606 lecithin Drugs 0.000 claims 2
- 235000010445 lecithin Nutrition 0.000 claims 2
- 239000000787 lecithin Substances 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 claims 1
- 238000010348 incorporation Methods 0.000 claims 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 150000002500 ions Chemical class 0.000 description 25
- 239000003921 oil Substances 0.000 description 16
- 239000002502 liposome Substances 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000011734 sodium Substances 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 241000331231 Amorphocerini gen. n. 1 DAD-2008 Species 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- -1 alkali metal salts Chemical class 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000905957 Channa melasoma Species 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 241000208140 Acer Species 0.000 description 1
- 101100190268 Caenorhabditis elegans pah-1 gene Proteins 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 101150039033 Eci2 gene Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000264060 Lethrinus Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 101100004031 Mus musculus Aven gene Proteins 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 235000004496 Oenothera biennis Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241001307210 Pene Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- IOVGROKTTNBUGK-SJCJKPOMSA-N ritodrine Chemical compound N([C@@H](C)[C@H](O)C=1C=CC(O)=CC=1)CCC1=CC=C(O)C=C1 IOVGROKTTNBUGK-SJCJKPOMSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000010496 thistle oil Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Colloid Chemistry (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4005711A DE4005711C1 (enExample) | 1990-02-23 | 1990-02-23 | |
| DEP4005711.9 | 1990-02-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2076625A1 true CA2076625A1 (en) | 1991-08-24 |
Family
ID=6400805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002076625A Abandoned CA2076625A1 (en) | 1990-02-23 | 1991-02-11 | Aqueous phospholipid vesicle dispersion, process for its manufacture and use thereof |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0629128B1 (enExample) |
| JP (1) | JPH05506397A (enExample) |
| AT (1) | ATE127336T1 (enExample) |
| CA (1) | CA2076625A1 (enExample) |
| DE (2) | DE4005711C1 (enExample) |
| DK (1) | DK0629128T3 (enExample) |
| ES (1) | ES2078510T3 (enExample) |
| GR (1) | GR3018064T3 (enExample) |
| WO (1) | WO1991012794A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5811119A (en) * | 1987-05-19 | 1998-09-22 | Board Of Regents, The University Of Texas | Formulation and use of carotenoids in treatment of cancer |
| US5160669A (en) * | 1988-03-03 | 1992-11-03 | Micro Vesicular Systems, Inc. | Method of making oil filled paucilamellar lipid vesicles |
| WO1993013751A1 (en) * | 1992-01-16 | 1993-07-22 | Board Of Regents, The University Of Texas System | Formulation and use of carotenoids in treatment of cancer |
| DE4338046A1 (de) * | 1993-11-08 | 1995-05-11 | Dietl Hans | Fettlösliche Arzneimittel erhaltende flüssige pharmazeutische Zubereitung zur oralen Anwendung |
| DE4420727A1 (de) * | 1994-06-15 | 1995-12-21 | Rovi Gmbh | Hautfreundliche wäßrige Liposomendispersionen, enthaltend alpha-Hydroxycarbonsäuren und/oder alpha-Hydroxyketosäuren in ihrer Salzform |
| FR2730928B1 (fr) * | 1995-02-23 | 1997-04-04 | Oreal | Composition a base de vesicules lipidiques a ph acide et son utilisation en application topique |
| DE19703368C1 (de) * | 1997-01-30 | 1998-10-01 | Klaus Dr Goebel | Verfahren zur Herstellung von Cremes |
| US8067032B2 (en) | 2000-12-22 | 2011-11-29 | Baxter International Inc. | Method for preparing submicron particles of antineoplastic agents |
| US6977085B2 (en) | 2000-12-22 | 2005-12-20 | Baxter International Inc. | Method for preparing submicron suspensions with polymorph control |
| US7193084B2 (en) | 2000-12-22 | 2007-03-20 | Baxter International Inc. | Polymorphic form of itraconazole |
| US6884436B2 (en) | 2000-12-22 | 2005-04-26 | Baxter International Inc. | Method for preparing submicron particle suspensions |
| US7037528B2 (en) | 2000-12-22 | 2006-05-02 | Baxter International Inc. | Microprecipitation method for preparing submicron suspensions |
| US6951656B2 (en) | 2000-12-22 | 2005-10-04 | Baxter International Inc. | Microprecipitation method for preparing submicron suspensions |
| US9700866B2 (en) | 2000-12-22 | 2017-07-11 | Baxter International Inc. | Surfactant systems for delivery of organic compounds |
| MXPA04002446A (es) | 2001-09-26 | 2004-07-23 | Baxter Int | Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente. |
| US20060003012A9 (en) | 2001-09-26 | 2006-01-05 | Sean Brynjelsen | Preparation of submicron solid particle suspensions by sonication of multiphase systems |
| US7112340B2 (en) | 2001-10-19 | 2006-09-26 | Baxter International Inc. | Compositions of and method for preparing stable particles in a frozen aqueous matrix |
| WO2006014035A1 (en) * | 2004-08-06 | 2006-02-09 | Biospectrum, Inc. | Multiple layered liposome and preparation method thereof |
| JP5412078B2 (ja) * | 2008-10-06 | 2014-02-12 | ドクタープログラム株式会社 | 皮膚外用剤 |
| JP2013136038A (ja) * | 2011-12-28 | 2013-07-11 | Miyoshi Oil & Fat Co Ltd | リポソームおよびその製造方法 |
| CH714305B1 (de) | 2017-11-06 | 2022-07-15 | Cosmetolab Ag | Verfahren zur Herstellung von topischen Formulierungen und hergestellte Formulierungen. |
| CN116019778B (zh) * | 2021-10-27 | 2025-04-04 | 嘉药学校财团法人嘉南药理大学 | 牡丹花蕊复合微晶囊体组合物的制作方法及其抗蓝光、保护细胞、抗过敏、与抗老化的用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55153713A (en) * | 1979-05-02 | 1980-11-29 | Kureha Chem Ind Co Ltd | Pharmaceutical preparation of ribosome containing active substance |
| EP0043327B1 (fr) * | 1980-07-01 | 1984-01-18 | L'oreal | Procédé d'obtention de dispersions stables dans une phase aqueuse d'au moins une phase liquide non miscible à l'eau et dispersions correspondantes |
| EP0088046B1 (de) * | 1982-02-17 | 1987-12-09 | Ciba-Geigy Ag | Lipide in wässriger Phase |
| DE3218027A1 (de) * | 1982-05-13 | 1983-11-17 | A. Nattermann & Cie GmbH, 5000 Köln | Phospholipidloesungen |
| SE457933B (sv) * | 1987-07-06 | 1989-02-13 | Larsson Kare | Farmaceutisk komposition innefattande en vattendispergerad blandning av lipider, monoglycerider och fosfatidylkolin samt dess anvaendning foer framstaellning av en gastronintestinalt verksam kompostion |
| WO1990012565A1 (en) * | 1989-04-25 | 1990-11-01 | Nattermann, A. & Cie. Gmbh | Water-containing formulations with phospholipids |
-
1990
- 1990-02-23 DE DE4005711A patent/DE4005711C1/de not_active Expired - Lifetime
-
1991
- 1991-02-11 JP JP91503964A patent/JPH05506397A/ja active Pending
- 1991-02-11 DE DE69112849T patent/DE69112849T2/de not_active Expired - Fee Related
- 1991-02-11 AT AT91903914T patent/ATE127336T1/de not_active IP Right Cessation
- 1991-02-11 DK DK91903914.9T patent/DK0629128T3/da active
- 1991-02-11 CA CA002076625A patent/CA2076625A1/en not_active Abandoned
- 1991-02-11 EP EP91903914A patent/EP0629128B1/en not_active Expired - Lifetime
- 1991-02-11 WO PCT/EP1991/000267 patent/WO1991012794A1/en not_active Ceased
- 1991-02-11 ES ES91903914T patent/ES2078510T3/es not_active Expired - Lifetime
-
1995
- 1995-11-10 GR GR950403162T patent/GR3018064T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK0629128T3 (da) | 1995-10-16 |
| DE69112849T2 (de) | 1996-11-07 |
| ATE127336T1 (de) | 1995-09-15 |
| JPH05506397A (ja) | 1993-09-22 |
| ES2078510T3 (es) | 1995-12-16 |
| DE4005711C1 (enExample) | 1991-06-13 |
| EP0629128B1 (en) | 1995-09-06 |
| EP0629128A1 (en) | 1994-12-21 |
| GR3018064T3 (en) | 1996-02-29 |
| DE69112849D1 (de) | 1995-10-12 |
| WO1991012794A1 (en) | 1991-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2076625A1 (en) | Aqueous phospholipid vesicle dispersion, process for its manufacture and use thereof | |
| EP0652010B1 (fr) | Utilisation d'un phosphate d'alpha-tocophérol, ou d'un de ses dérivés pour la préparation d'une composition cosmétique, dermatologique ou pharmaceutique, à activité anti-radicalaire ; composition ainsi obtenue | |
| CA1208133A (en) | Pulverulent mixture of lipidic constituents and hydrop hobic constituents, methods for obtaining the same hyd rated lipidic lamellar phases and method for producing the same, pharmaceutical or cosmetic compositions com prising hydrated lipidic lamellar phases | |
| US4186183A (en) | Liposome carriers in chemotherapy of leishmaniasis | |
| EP0665000B1 (fr) | Composition hydratante pour le traitement simultané des couches superficielles et profondes de la peau, son utilisation | |
| US20040126367A1 (en) | Stable solution of reduced coenzyme q | |
| US8003635B2 (en) | Superoxide dismutase mimics for the treatment of ocular disorders and diseases | |
| WO2008109031A2 (en) | Liposome carriers for in vivo delivery of fullerenes | |
| HUE033256T2 (hu) | Kétfázisú lipidvezikulum készítmény és eljárás cervikális diszplázia kezelésére intravaginális adagolással | |
| CA2505608A1 (en) | Superoxide dismutase mimics for the treatment of ocular disorders and diseases | |
| US4594241A (en) | Anti-leishmanial pharmaceutical formulations | |
| MXPA06005688A (es) | Composiciones estables de liposoma que comprenden una amina lipofilica que contiene agentes farmaceuticos. | |
| US6194401B1 (en) | Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of α-glycerophosphoric acid | |
| EP1567166B1 (en) | Superoxide dismutase mimics for the treatment of ocular disorders and diseases | |
| RU2102972C1 (ru) | Водная эмульсия перфторуглеродов | |
| JP2747317B2 (ja) | 皮膚の健康を維持または回復する薬剤 | |
| IE920400A1 (en) | Pharmaceutical product for the treatment of virus diseases | |
| EP1137407B1 (en) | Ophthalmic formulation comprising a beta blocker and carbopol | |
| RU2114627C1 (ru) | Водная эмульсия перфторуглеродов | |
| IE920401A1 (en) | Pharmaceutical product for the treatment of virus diseases | |
| JP2003535030A (ja) | 保存リポソーム | |
| JPH04208216A (ja) | 微細リポソームの調製法 | |
| AU2002351267B8 (en) | Superoxide dismutase mimics for the treatment of ocular disorders and diseases | |
| Musheer et al. | Formulation, Development and Characterization of Effective Niosomal Drug Delivery System for the Treatment of Diabetes Mellitus | |
| JPH0610131B2 (ja) | リポソームの製法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |